Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Protalix BioTherapeutics (PLX) Times Interest Earned (2016 - 2025)

Historic Times Interest Earned for Protalix BioTherapeutics (PLX) over the last 13 years, with Q1 2025 value amounting to -$690.83.

  • Protalix BioTherapeutics' Times Interest Earned fell 544829.08% to -$690.83 in Q1 2025 from the same period last year, while for Sep 2025 it was $135.47, marking a year-over-year increase of 284221.35%. This contributed to the annual value of $3.69 for FY2024, which is 1213.07% up from last year.
  • As of Q1 2025, Protalix BioTherapeutics' Times Interest Earned stood at -$690.83, which was down 544829.08% from $175.83 recorded in Q4 2024.
  • In the past 5 years, Protalix BioTherapeutics' Times Interest Earned registered a high of $175.83 during Q4 2024, and its lowest value of -$690.83 during Q1 2025.
  • For the 5-year period, Protalix BioTherapeutics' Times Interest Earned averaged around -$32.45, with its median value being -$4.1 (2023).
  • In the last 5 years, Protalix BioTherapeutics' Times Interest Earned skyrocketed by 252371.96% in 2024 and then plummeted by 544829.08% in 2025.
  • Protalix BioTherapeutics' Times Interest Earned (Quarter) stood at -$6.28 in 2021, then soared by 38.92% to -$3.84 in 2022, then crashed by 89.0% to -$7.25 in 2023, then surged by 2523.72% to $175.83 in 2024, then tumbled by 492.9% to -$690.83 in 2025.
  • Its last three reported values are -$690.83 in Q1 2025, $175.83 for Q4 2024, and $15.35 during Q3 2024.